Literature DB >> 18698805

Comparative proteomic analysis of matched primary and metastatic melanoma cell lines.

Mohammad Al-Ghoul1, Thomas B Brück, Janelle L Lauer-Fields, Victor S Asirvatham, Claudia Zapata, Russell G Kerr, Gregg B Fields.   

Abstract

Identification of the biochemical pathways involved in the transformation from primary to metastatic melanoma is an area under intense investigation. A 2DE proteomics approach has been applied herein to the matched patient primary and metastatic melanoma cell lines WM-115 and WM-266-4, respectively, to better understand the processes that underlie tumor progression. Image analysis between samples aligned 470 common gel spots. Quantitative gel analysis indicated 115 gel spots of greater intensity in the metastatic line compared with the primary one, leading to the identification of 131 proteins via database searching of nano-LC-ESI-Q-TOF-MS/MS data. This more than tripled the number of proteins previously shown to be of higher abundance during melanoma progression. Also observed were 22 gel spots to be of lesser intensity in the metastatic line with respect to the primary one. Of these gel spots 15 proteins could be identified. Numerous proteins from both groups had not been reported previously to participate in melanoma progression. Further analysis of one protein, cyclophilin A, confirmed that this protein is expressed at higher levels in metastatic melanoma compared with primary melanoma and normal fibroblasts. Overall, this study expands our knowledge of protein modulation during melanoma stages, and suggests new targets for inhibitor development.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18698805     DOI: 10.1021/pr800174k

Source DB:  PubMed          Journal:  J Proteome Res        ISSN: 1535-3893            Impact factor:   4.466


  16 in total

1.  Proteome analysis of the effects of sorafenib on human hepatocellular carcinoma cell line HepG2.

Authors:  Aili Suo; Mingxin Zhang; Yu Yao; Lingmin Zhang; Chen Huang; Kejun Nan; Wanggang Zhang
Journal:  Med Oncol       Date:  2011-07-07       Impact factor: 3.064

2.  Selected reaction monitoring approach for validating peptide biomarkers.

Authors:  Qing Wang; Ming Zhang; Tyler Tomita; Joshua T Vogelstein; Shibin Zhou; Nickolas Papadopoulos; Kenneth W Kinzler; Bert Vogelstein
Journal:  Proc Natl Acad Sci U S A       Date:  2017-12-04       Impact factor: 11.205

3.  Molecular cloning, expression, and characterization of cyclophilin A from Clonorchis sinensis.

Authors:  Weihua Wu; Jiajia Chen; Suxiang Zeng; Zhaoping Zhang; Wenjia Gan; Xinbing Yu; Xuchu Hu
Journal:  Parasitol Res       Date:  2011-03-01       Impact factor: 2.289

4.  Proline isomerisation as a novel regulatory mechanism for p38MAPK activation and functions.

Authors:  A Brichkina; N Tm Nguyen; R Baskar; S Wee; J Gunaratne; R C Robinson; D V Bulavin
Journal:  Cell Death Differ       Date:  2016-05-27       Impact factor: 15.828

5.  Identification of additional proteins in differential proteomics using protein interaction networks.

Authors:  Frederik Gwinner; Adelina E Acosta-Martin; Ludovic Boytard; Maggy Chwastyniak; Olivia Beseme; Hervé Drobecq; Sophie Duban-Deweer; Francis Juthier; Brigitte Jude; Philippe Amouyel; Florence Pinet; Benno Schwikowski
Journal:  Proteomics       Date:  2013-04       Impact factor: 3.984

6.  Oncogenic heterogeneous nuclear ribonucleoprotein D-like modulates the growth and imatinib response of human chronic myeloid leukemia CD34+ cells via pre-B-cell leukemia homeobox 1.

Authors:  Dehuan Ji; Pengshan Zhang; Wenjuan Ma; Yiwen Fei; Wen Xue; Yu Wang; Xiuyan Zhang; Haixia Zhou; Yun Zhao
Journal:  Oncogene       Date:  2019-09-05       Impact factor: 9.867

7.  Cyclophilin A Inhibitor Debio-025 Targets Crk, Reduces Metastasis, and Induces Tumor Immunogenicity in Breast Cancer.

Authors:  Viralkumar Davra; Sushil Kumar; Tamjeed Saleh; Ke Geng; Stanley Kimani; Dhriti Mehta; Canan Kasikara; Brendan Smith; Nicholas W Colangelo; Bryan Ciccarelli; Hong Li; Edouard I Azzam; Charalampos G Kalodimos; Raymond B Birge
Journal:  Mol Cancer Res       Date:  2020-04-22       Impact factor: 5.852

Review 8.  Current implications of cyclophilins in human cancers.

Authors:  Jinhwa Lee; Sung Soo Kim
Journal:  J Exp Clin Cancer Res       Date:  2010-07-19

9.  Identification of tyrosine-phosphorylated proteins associated with metastasis and functional analysis of FER in human hepatocellular carcinoma cells.

Authors:  Haiyu Li; Zhenggang Ren; Xiaonan Kang; Lan Zhang; Xuefei Li; Yan Wang; Tongchun Xue; Yuefang Shen; Yinkun Liu
Journal:  BMC Cancer       Date:  2009-10-16       Impact factor: 4.430

10.  Downregulation of cyclophilin A by siRNA diminishes non-small cell lung cancer cell growth and metastasis via the regulation of matrix metallopeptidase 9.

Authors:  Zhe Qian; Xiaoting Zhao; Mei Jiang; Wenyun Jia; Chunyan Zhang; Yue Wang; Baolan Li; Wentao Yue
Journal:  BMC Cancer       Date:  2012-10-02       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.